Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christina Sauerland"'
Autor:
Burkhard Greve, Tobias Bölling, Susanne Amler, Ute Rössler, Maria Gomolka, Claudia Mayer, Odilia Popanda, Kristin Dreffke, Astrid Rickinger, Eberhard Fritz, Friederike Eckardt-Schupp, Christina Sauerland, Herbert Braselmann, Wiebke Sauter, Thomas Illig, Dorothea Riesenbeck, Stefan Könemann, Normann Willich, Simone Mörtl, Hans Theodor Eich, Peter Schmezer
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47185 (2012)
Radiotherapy is a powerful cure for several types of solid tumours, but its application is often limited because of severe side effects in individual patients. With the aim to find biomarkers capable of predicting normal tissue side reactions we anal
Externí odkaz:
https://doaj.org/article/02319a24f0e3479fac22b5f76f949cf0
Autor:
Wolfgang Hiddemann, Eike Bormann, Christoph Schliemann, Caroline Pabst, Linus Angenendt, Tobias Herold, Guy Sauvageau, Maria Francisca Arteaga, Klaus H. Metzeler, Klaus Wethmar, Wolfgang E. Berdel, Hubert Serve, Vijay Alla, Jan-Henrik Mikesch, Carsten Müller-Tidow, Georg Lenz, Kim Dohlich, Bob Löwenberg, Wolfgang Hartmann, Torsten Kessler, Adrian Angenendt, Matthias Stelljes, Rolf M. Mesters, Peter J. M. Valk, Karsten Spiekermann, Josée Hébert, Dennis Görlich, Stefan K. Bohlander, Utz Krug, Christian Schwöppe, M Christina Sauerland, Bernhard Wörmann, Leonie Braun, Maja Rothenberg-Thurley
Publikováno v:
Leukemia 33, 2830-2841 (2019)
Leukemia, 33(12), 2830-2841. Nature Publishing Group
Leukemia, 33(12), 2830-2841. Nature Publishing Group
Calcitonin receptor-like (CALCRL) is a G-protein-coupled neuropeptide receptor involved in the regulation of blood pressure, angiogenesis, cell proliferation, and apoptosis, and is currently emerging as a novel target for the treatment of migraine. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845323dcc3018ec9a3bc8d294f1472fe
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56286
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56286
Autor:
Thomas Büchner, Helmut Blum, Klaus H. Metzeler, Marion Subklewe, Tobias Herold, Jan Braess, Vindi Jurinovic, Stefan Bamopoulos, Ulrich Mansmann, Susanne Amler, Wolfgang Hiddemann, Luise Hartmann, Stefan Krebs, Karsten Spiekermann, Bianka Ksienzyk, Maja Rothenberg-Thurley, Stephanie Schneider, Dennis Görlich, Aarif M. N. Batcha, Christina Sauerland, Michael Fiegl, Wolfgang E. Berdel, Philipp A. Greif, Stefan K. Bohlander, Bernhard Wörmann, Julia Phillippou-Massier
Publikováno v:
Blood. 128:1209-1209
About 20-25% of patients with Acute Myeloid Leukemia (AML) have primary drug resistant disease and fail to achieve complete remission after induction therapy. These patients have an extremely poor prognosis and cannot reliably be identified prior to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91c751903b911e85bbb91e6a24b9370d
https://doi.org/10.1182/blood.v128.22.1209.1209
https://doi.org/10.1182/blood.v128.22.1209.1209
Autor:
Christina Sauerland, Evelyn Zellmeier, Karsten Spiekermann, Annika Dufour, Bianka Ksienzyk, Stephanie Schneider, Stefan K. Bohlander, Wolfgang E. Berdel, Kathrin Bräundl, Max Hubmann, Jan Braess, Philipp A. Greif, Wolfgang Hiddemann, Bernhard Wörmann, Egor Harin, Katrin Reiter, Sebastian Vosberg, Thomas Büchner
Publikováno v:
Blood. 128:1682-1682
Introduction In Acute Myeloid Leukemia (AML) internal tandem duplications (ITD) in the fms-related tyrosine kinase 3 (FLT3) are a frequent event associated with an unfavorable prognosis. At diagnosis, the FLT3-ITD status is routinely assessed by frag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1e289626d5b785beeb8004a4ecf122e
https://doi.org/10.1182/blood.v128.22.1682.1682
https://doi.org/10.1182/blood.v128.22.1682.1682
Autor:
Stefan Könemann, Friederike Eckardt-Schupp, Herbert Braselmann, Peter Schmezer, Odilia Popanda, Normann Willich, Wiebke Sauter, Tobias Bölling, Claudia Mayer, Maria Gomolka, Thomas Illig, Eberhard Fritz, Dorothea Riesenbeck, Hans Theodor Eich, Susanne Amler, Ute Rössler, Christina Sauerland, Astrid Rickinger, Kristin Dreffke, Simone Mörtl, Burkhard Greve
Publikováno v:
PLoS ONE 7:e47185 (2012)
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e47185 (2012)
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e47185 (2012)
Radiotherapy is a powerful cure for several types of solid tumours, but its application is often limited because of severe side effects in individual patients. With the aim to find biomarkers capable of predicting normal tissue side reactions we anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f146533219785bda4e7b2db975e099
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=11024
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=11024
Autor:
Georg Maschmeyer, Wolfgang E. Berdel, Nadja Jaekel, Vladan Vucinic, Ute Hegenbart, Ute Kreibich, Hans-Heinrich Wolf, Bernhard Opitz, Haifa Kathrin Al-Ali, Christian Jakob, Verena S. Hoffmann, Wolfgang Hiddemann, Dietger Niederwieser, Markus Pfirrmann, Norma Peter, Michael Cross, Thomas Heinicke, Christina Sauerland, C Busemann, Christian Junghanss, Alwin Kraemer, Rainer Krahl, Stefan K. Bohlander, Sebastian Scholl, Karsten Spiekermann, Thomas Buechner, Utz Krug, Wolfram Poenisch, Detlev Haehling, Ahmet H. Elmaagacli, Antje Schulze
Publikováno v:
Blood. 126:2517-2517
Background The German AML Intergroup conducted two randomized studies in younger ( Patients and Methods The East German Study Group (OSHO) and the Acute Myeloid Leukemia Cooperative Group (AMLCG) each entered patients from 18 to 59 years into one stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec1f96a3fc9d1187e40ed20dbc86f81
https://doi.org/10.1182/blood.v126.23.2517.2517
https://doi.org/10.1182/blood.v126.23.2517.2517
Autor:
Michael Unterhalt, Hubert Serve, Albrecht Reichle, Xaver Schiel, Christoph Schmid, Achim Heinecke, Daniel Oruzio, Bernhard Wörmann, Herrad Baurmann, Michael Fiegl, Christina Sauerland, Wolfgang E. Berdel, Marcus Hentrich, Karsten Spiekermann, Thomas Büchner, Jan Braess, Wolfgang Hiddemann, Wolf-Dieter Ludwig, Christian Buske, Wolfgang Kern, Rudolf Peceny, Andreas Grüneisen, Dietrich W. Beelen, Peter Staib, Stefan K. Bohlander
Dose density during early induction has been demonstrated to be one of the prime determinants for treatment efficacy in acute myeloid leukemia (AML). The German AML Cooperative Group has therefore piloted a dose-dense induction regimen sequential hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f70e1a7ef42a7abe5f8440f3bc41b06
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/99327
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/99327
Autor:
Maria-Christina Sauerland, T. Büchner, Regine Rottmann, Achim Heinecke, Michael Zühlsdorf, Wolfgang Hiddemann, Georg Innig, Wolf-Dieter Ludwig, Georg Maschmeier, Bernhard Wörmann
Hematopoietic growth factors (GFs) are administered to patients who have acute myeloid leukemia (AML) in order to overcome two limitations of chemotherapy: (I) myelotoxicity, and (2) the chemoresistance of minimal residual disease. GFs have been used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::404fc5730bae524616421ee5a9dc69fc
https://doi.org/10.1159/000425783
https://doi.org/10.1159/000425783
Autor:
Christian Sperling, Thomas Buuchner, Ursula Creutzig, Jourg Ritter, Jochen Harbott, Christa Fonatsch, Christina Sauerland, Marco Mielcarek, Georg Maschmeyer, Helmut Louffler, Wolf Dieter Ludwig
Publikováno v:
Leukemialymphoma. 17(5-6)
Expression of CD34 by leukemic blasts was analyzed in 230 pediatric and 251 adult patients with de novo AML enrolled in two large multicenter trials (AML-BFM-87 and AMLCG respectively). The association between CD34 positivity and morphological classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1493c68d150082c68e18f9c270c7d246
https://pubmed.ncbi.nlm.nih.gov/7549832
https://pubmed.ncbi.nlm.nih.gov/7549832
Autor:
Susanne Schnittger, Wolfgang Hiddemann, Heinz A. Horst, Claudia Haferlach, Achim Heinecke, Thomas Büchner, Wolf-Karsten Hofmann, Benjamin Hanfstein, Karsten Spiekermann, Rüdiger Hehlmann, Wolfgang E. Berdel, Maria-Christina Sauerland, Hubert Serve, Jan Braess, Philipp Erben, Bernhard J. Woermann, Utz Krug, Torsten Haferlach, Karl-Anton Kreuzer, Eva Lengfelder
Publikováno v:
Blood. 118:425-425
Abstract 425 The introduction of all-trans-retinoic acid (ATRA) in front line therapy of acute promyelocytic leukemia (APL) has improved the outcome of all age groups. In the elderly patients (pts), multi-morbidity and higher vulnerability to chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0b59df03c2073759eee3deacb1fa874
https://doi.org/10.1182/blood.v118.21.425.425
https://doi.org/10.1182/blood.v118.21.425.425